+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin



Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin



Official Gazette of the United States Patent & Trademark Office Patents 1229(1), Dec 7



The present invention relates to methods of treating or preventing cancer by administration of human chorionic gonadotropin, beta-human chorionic gonadotropin or a peptide containing a sequence of a portion of beta-human chorionic gonadotropin. In a preferred embodiment, the invention provides methods of treating or preventing Kaposi's Sarcoma, breast cancer or prostate cancer. in another preferred embodiment, the invention relates to beta-human chorionic gonadotropin peptides for treatment or prevention of cancer. The invention further provides assays for the utility of particular human chorionic gonadotropin preparations in the treatment or prevention of cancer. Pharmaceutical compositions and methods of administration are also provided.

(PDF emailed within 1 workday: $29.90)

Accession: 035980011

Download citation: RISBibTeXText


Related references

Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin. Official Gazette of the United States Patent & Trademark Office Patents 1252(3), Nov 20, 2001

Plasma levels of luteinizing hormone human chorionic gonadotropin in male subjects following intra venous administration of human chorionic gonadotropin or oral treatment with clomiphene. Acta Endocrinologica Supplementum 159: 109, 1972

Administration of human chorionic gonadotropin to suckled beef cows before ovulation synchronization and fixed-time insemination: replacement of gonadotropin-releasing hormone with human chorionic gonadotropin. Journal of Animal Science 89(10): 3030-3039, 2012

The testicular response to human chorionic gonadotropin and human chorionic gonadotropin human menopausal gonadotropin treatment in patients with hypogonadotropic eunuchoidism influence of endogenous fsh. Journal of Steroid Biochemistry 20(6 PART B): 1603, 1984

The preparation of a human chorionic gonadotropin specific immunoadsorbent using human chorionic gonadotropin beta carboxyl terminal peptide antibody and its application to isolate human chorionic gonadotropin like substances from human pituitary glands. Folia Endocrinologica Japonica 60(6): 800-813, 1984

Individualized treatment and hormonal patterns during administration of human menopausal gonadotropin human chorionic gonadotropin in anovulatory women. Acta Obstetrica et Gynaecologica Japonica (Japanese Edition) 33(6): 777-785, 1981

Monitoring of follicles by ultrasonography during induction with human menopausal gonadotropin human chorionic gonadotropin treatment especially on the prevention of side effects. Acta Obstetrica et Gynaecologica Japonica (Japanese Edition) 37(5): 721-729, 1985

A specific radio immunoassay of a human chorionic gonadotropin beta subunit in the presence of native human chorionic gonadotropin and immunological biological and chemical characterization of human chorionic gonadotropin and its chemically modified subunits. Folia Endocrinologica Japonica 55(1): 38-53, 1979

Effects of human chorionic gonadotropin asialo human chorionic gonadotropin and human chorionic gonadotropin alpha and beta subunits upon luteinization of monkey granulosa cell cultures. Federation Proceedings: 257, 1972

Fundamental and clinical evaluation of human chorionic gonadotropin radio immunoassay using iodine 125 labeled human chorionic gonadotropin and anti beta human chorionic gonadotropin system. Kaku Igaku 19(4): 607, 1982

Gonadotropin-releasing hormone effects on placental hormones during gestation: I. Alpha-human chorionic gonadotropin, human chorionic gonadotropin and human chorionic somatomammotropin. Biology of Reproduction 34(2): 245-254, 1986

Typical pattern of human chorionic gonadotropin human chorionic gonadotropin alpha and human chorionic gonadotropin beta serum concentrations in molar pregnancies. Acta Endocrinologica Supplementum 212: 33, 1977

The carbohydrate moiety of human chorionic gonadotropin lack of competition with human chorionic gonadotropin for testicular receptors and anti human chorionic gonadotropin serum. Hormone & Metabolic Research 11(2): 165-167, 1979

Rapid human chorionic gonadotropin part 2 time variations in blood luteinizing hormone follicle stimulating hormone testosterone estrogen and dehydroepi androsterone after human chorionic gonadotropin administration. Folia Endocrinologica Japonica 50(2): 316, 1974

Expression and regulation of luteinizing hormone/human chorionic gonadotropin receptors in ovarian cancer and its correlation to human chorionic gonadotropin-doxorubicin sensitivity. American Journal of Obstetrics and Gynecology 190(6): 1621-8; Discussion 1628, 2004